Equities
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,704.00
  • Today's Change-14.00 / -0.81%
  • Shares traded81.55k
  • 1 Year change-18.55%
  • Beta0.2774
Data delayed at least 20 minutes, as of Nov 25 2024 13:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade, Genus PLC (GNS:LSE) traded at 1,704.00, 15.30% above the 52 week low of 1,477.83 set on Feb 15, 2024.
52-week range
Today
1,477.83Feb 15 20242,378.00Jan 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open1,740.00
High1,740.00
Low1,696.00
Bid1,698.00
Offer1,704.00
Previous close1,718.00
Average volume77.80k
Shares outstanding66.03m
Free float65.54m
P/E (TTM)144.83
Market cap1.13bn GBP
EPS (TTM)0.1186
GBP
Annual div (ADY)32.00
GBX
Annual div yield (ADY)1.86%
Div ex-dateNov 07 2024
Div pay-dateDec 06 2024
Data delayed at least 20 minutes, as of Nov 25 2024 13:59 GMT.
More ▼
  • Retail & Consumer industry

    Genus board goes on buying spree

    Directors of animal genetics group hope its share price has bottomed while Jet2’s Philip Meeson makes a big sale

  • Legal services

    Practice of law: case studies

    Featuring the most innovative services that lawyers have developed for clients

Investors Chronicle View

The last IC recommendation on Genus PLC shares was Hold at 1,734.00 on 05 Sep 2024Read the full article
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.